"Ribavirin/pharmacology"[MAJR] - Search Results

Year	Number of Results
1974	1
1975	4
1976	5
1977	13
1978	11
1979	11
1980	12
1981	9
1982	15
1983	13
1984	19
1985	15
1986	11
1987	19
1988	22
1989	32
1990	38
1991	25
1992	10
1993	15
1994	13
1995	13
1996	15
1997	12
1998	25
1999	28
2000	53
2001	66
2002	103
2003	115
2004	146
2005	161
2006	145
2007	136
2008	163
2009	170
2010	154
2011	205
2012	199
2013	166
2014	160
2015	161
2016	141
2017	83
2018	75
2019	59
2020	43
2021	26
2022	12
2023	3
2024	2

1

Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients.

Marcelin JR, Wilson JW, Razonable RR; Mayo Clinic Hematology/Oncology and Transplant Infectious Diseases Services. Marcelin JR, et al. Transpl Infect Dis. 2014 Apr;16(2):242-50. doi: 10.1111/tid.12194. Epub 2014 Mar 13. Transpl Infect Dis. 2014. PMID: 24621016

2

Ribavirin pharmacokinetics.

Connor J. Connor J. Pediatr Infect Dis J. 1990 Sep;9(9 Suppl):S91-2. doi: 10.1097/00006454-199009001-00009. Pediatr Infect Dis J. 1990. PMID: 2235214 Review. No abstract available.

3

Ribavirin's antiviral mechanism of action: lethal mutagenesis?

Crotty S, Cameron C, Andino R. Crotty S, et al. J Mol Med (Berl). 2002 Feb;80(2):86-95. doi: 10.1007/s00109-001-0308-0. Epub 2001 Dec 4. J Mol Med (Berl). 2002. PMID: 11907645 Review.

4

Inadequate numbers.

Lindsay KL, Greene MF, Jones JK, Maddrey WC, Miller RK. Lindsay KL, et al. Can Fam Physician. 2007 Mar;53(3):401; author reply 401-2. Can Fam Physician. 2007. PMID: 17872667 Free PMC article. No abstract available.

5

Final results from the ribavirin pregnancy registry, 2004-2020.

Sinclair SM, Jones JK, Miller RK, Greene MF, Kwo PY, Maddrey WC. Sinclair SM, et al. Birth Defects Res. 2022 Dec 1;114(20):1376-1391. doi: 10.1002/bdr2.2094. Epub 2022 Oct 28. Birth Defects Res. 2022. PMID: 36305304

6

Dosing ribavirin in hepatitis E-infected solid organ transplant recipients.

De Winter BCM, Hesselink DA, Kamar N. De Winter BCM, et al. Pharmacol Res. 2018 Apr;130:308-315. doi: 10.1016/j.phrs.2018.02.030. Epub 2018 Feb 27. Pharmacol Res. 2018. PMID: 29499270 Review.

7

Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses.

Westover JB, Sefing EJ, Bailey KW, Van Wettere AJ, Jung KH, Dagley A, Wandersee L, Downs B, Smee DF, Furuta Y, Bray M, Gowen BB. Westover JB, et al. Antiviral Res. 2016 Feb;126:62-8. doi: 10.1016/j.antiviral.2015.12.006. Epub 2015 Dec 19. Antiviral Res. 2016. PMID: 26711718 Free PMC article.

8

Ribavirin monitoring in chronic hepatitis C therapy: anaemia versus efficacy.

Brochot E, Castelain S, Duverlie G, Capron D, Nguyen-Khac E, François C. Brochot E, et al. Antivir Ther. 2010;15(5):687-95. doi: 10.3851/IMP1609. Antivir Ther. 2010. PMID: 20710050 Review.

9

Molecular mechanisms of action of ribavirin.

Patterson JL, Fernandez-Larsson R. Patterson JL, et al. Rev Infect Dis. 1990 Nov-Dec;12(6):1139-46. doi: 10.1093/clinids/12.6.1139. Rev Infect Dis. 1990. PMID: 2267489 Review.

10

Influence of Ribavirin on Mumps Virus Population Diversity.

Jurković M, Slović A, Forčić D, Ivančić-Jelečki J, Košutić-Gulija T, Jagušić M. Jurković M, et al. Viruses. 2021 Dec 17;13(12):2535. doi: 10.3390/v13122535. Viruses. 2021. PMID: 34960805 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

2,882 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

2,882 results

Results by year